The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Reports |

Symptomatic Exacerbation of Crohn Disease after Treatment with High-Dose Interleukin-2

Joseph A. Sparano, MD; Lawrence J. Brandt, MD; Janice P. Dutcher, MD; Jon S. Dubois, MD; and Michael B. Atkins, MD
[+] Article, Author, and Disclosure Information

From Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York; New England Medical Center, Boston, Massachusetts. Requests for Reprints: Joseph A. Sparano, MD, Albert Einstein Cancer Center, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467. Acknowledgments: The authors thank Dr. Panna Mahadevia who assisted in reviewing the pathologic material. Grant Support: In part by a grant from the National Institutes of Health (CA P30CA1130) and an American Cancer Society Career Development Award (JAS, 92-274).

Copyright 2004 by the American College of Physicians

Ann Intern Med. 1993;118(8):617-618. doi:10.7326/0003-4819-118-8-199304150-00007
Text Size: A A A

Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention. At laparotomy, both patients had histologic evidence of active Crohn disease. One patient had previously received another cytokine, -interferon-, without disease reactivation, suggesting that this effect was specific for IL-2. The striking temporal relation between the administration of IL-2 and the symptomatic reactivation of previously quiescent Crohn disease suggests the need to carefully evaluate patients with a history of inflammatory bowel disease who are considered for IL-2 therapy and provides evidence supporting an important role for IL-2 in the pathogenesis of Crohn disease.


Grahic Jump Location
Figure 1.
Sigmoid colon.long arrowsshort open arrow

Photograph of the sigmoid colon showing a deep-fissure ulcer ( ) lined by granulation tissue ( ) (original magnification, 10).

Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Journal Club
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.